» Articles » PMID: 12069024

Sequelae After Bacterial Meningitis in Childhood

Overview
Publisher Informa Healthcare
Date 2002 Jun 19
PMID 12069024
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The neurological outcome of bacterial meningitis in children was evaluated retrospectively. Data were obtained from a large study on children aged between 1 month and 15 y who initially visited the emergency department of Sophia Children's Hospital, Rotterdam, The Netherlands with meningeal signs. This study presents data from 103 patients in whom bacterial meningitis was diagnosed. Neisseria meningitidis was the dominant pathogen of meningitis. We found a 2% case-fatality rate in children with bacterial meningitis and a 13% rate of sequelae among survivors: 7% hearing impairment and 7% neurological sequelae. Children with bacterial meningitis caused by Streptococcus pneumoniae and those with acute focal neurological symptoms tended to have the worst prognosis.

Citing Articles

Serial cerebrospinal fluid concentrations of high mobility group box 1 in bacterial meningitis: a retrospective cohort study.

Matsushige T, Inoue H, Hoshide M, Kohno F, Kobayashi H, Ichihara K BMC Infect Dis. 2025; 25(1):107.

PMID: 39849347 PMC: 11756128. DOI: 10.1186/s12879-025-10476-7.


Hospital-based Surveillance Provides Insights Into the Etiology of Pediatric Bacterial Meningitis in Yaoundé, Cameroon, in the Post-Vaccine Era.

Boula A, Senghore M, Ngoh R, Tassadjo F, Fonkoua M, Nzouankeu A Clin Infect Dis. 2019; 69(Suppl 2):S148-S155.

PMID: 31505633 PMC: 6761319. DOI: 10.1093/cid/ciz506.


Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers.

Olbrich K, Muller D, Schumacher S, Beck E, Meszaros K, Koerber F Infect Dis Ther. 2018; 7(4):421-438.

PMID: 30267220 PMC: 6249177. DOI: 10.1007/s40121-018-0213-2.


Trends in the prevalence of autism spectrum disorder, cerebral palsy, hearing loss, intellectual disability, and vision impairment, metropolitan atlanta, 1991-2010.

Braun K, Christensen D, Doernberg N, Schieve L, Rice C, Wiggins L PLoS One. 2015; 10(4):e0124120.

PMID: 25923140 PMC: 4414511. DOI: 10.1371/journal.pone.0124120.


Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.

Hepkema H, Pouwels K, van der Ende A, Westra T, Postma M PLoS One. 2013; 8(5):e65036.

PMID: 23741448 PMC: 3669019. DOI: 10.1371/journal.pone.0065036.